NDC codes

415464 NDC codes with hospital pricing data in the network.

• NDC 83490-0220-28 — Nebulizer medicationAI (24 hospitals, 30,291–31,155 samples)
• NDC 09991-2208-00 — Sodium phosphate in sodium chloride IV solutionAI (24 hospitals, 30,291–31,155 samples)
• NDC 09990-8538-00 — Ferric subsulfate topical solution with applicatorAI (24 hospitals, 30,291–31,155 samples)
• NDC 09991-2387-00 — Ketamine 2 mg/mL in saline IV solutionAI (24 hospitals, 30,291–31,155 samples)
• NDC 04879-0501-01 — Albuterol sulfate 2.5 mg nebulizer solutionAI (27 hospitals, 30,291–31,155 samples)
• NDC 09990-4340-00 — Ipratropium and albuterol nebulizer solutionAI (24 hospitals, 30,291–31,155 samples)
• NDC 00054-0010-25 — Flecainide 50 mg tabletsAI (200 hospitals, 30,668–31,154 samples)
• NDC 44567-0701-25 — Ceftriaxone sodium 1 g injection powderAI (610 hospitals, 18,805–31,144 samples)
• NDC 00065-0092-65 — Fluorescein 10% injection for eye imagingAI (496 hospitals, 30,226–31,144 samples)
• NDC 00409-1208-11 — Cisatracurium besylate injection, 20 mg/10 mL IVAI (183 hospitals, 30,185–31,130 samples)
• NDC 00116-4005-15 — Lactulose oral solution 20 g per 30 mLAI (102 hospitals, 30,103–31,129 samples)
• NDC 59762-0131-06 — SILVER SULFADIAZINE 1 % TOPICAL CREAMAI (119 hospitals, 30,147–31,128 samples)
• NDC 00409-1559-19 — Bupivacaine 0.25% preservative-free injectionAI (172 hospitals, 29,779–31,120 samples)
• NDC 51383-0003-14 — Sodium chloride and hypochlorous acid irrigation solutionAI (88 hospitals, 30,391–31,111 samples)
• NDC 10019-0553-03 — Scopolamine 1 mg transdermal patch (3-day)AI (480 hospitals, 29,788–31,093 samples)
• NDC 00338-0017-38 — Dextrose 5% intravenous solutionAI (381 hospitals, 29,658–31,089 samples)
• NDC 00116-4005-40 — Lactulose oral solutionAI (58 hospitals, 30,099–31,089 samples)
• NDC 81033-0241-50 — Lactulose oral solutionAI (35 hospitals, 30,099–31,089 samples)
• NDC 81033-0241-15 — Lactulose oral solution, 15 mL cupAI (84 hospitals, 30,099–31,089 samples)
• NDC 66689-0039-01 — Lactulose 10 g/15 mL oral solutionAI (102 hospitals, 30,099–31,089 samples)
• NDC 00003-0894-21 — apixaban 5 mg tabletAI (630 hospitals, 30,027–31,080 samples)
• NDC 50383-0779-30 — Lactulose 10 g/15 mL oral solutionAI (198 hospitals, 30,098–31,079 samples)
• NDC 65862-0391-10 — Ondansetron 8 mg dissolving tabletAI (469 hospitals, 27,045–31,077 samples)
• NDC 00168-0057-60 — BETAMETHASONE DIPROPIONATE 0.05 % LOTIONAI (160 hospitals, 30,081–31,071 samples)
• NDC 63323-0495-41 — Lidocaine injection (2%, preservative-free)AI (144 hospitals, 28,068–31,065 samples)
• NDC 60687-0595-01 — Famotidine 20 mg tabletsAI (465 hospitals, 29,703–31,053 samples)
• NDC 68462-0433-18 — Colesevelam 625 mg oral tabletsAI (270 hospitals, 30,501–31,032 samples)
• NDC 72485-0508-01 — Etomidate 2 mg/mL intravenous solutionAI (191 hospitals, 30,175–31,030 samples)
• NDC 00338-0704-34 — Potassium chloride in saline IV solutionAI (799 hospitals, 29,244–31,026 samples)
• NDC 70121-1049-01 — Triamcinolone acetonide injectable suspension, 40 mg/mLAI (635 hospitals, 25,707–31,008 samples)
• NDC 49502-0806-32 — Revefenacin 175 mcg nebulizer solutionAI (230 hospitals, 30,101–31,001 samples)
• NDC 17478-0284-35 — Gentamicin antibiotic ointment, 3.5 g tubeAI (352 hospitals, 30,131–30,995 samples)
• NDC 00641-6209-01 — Midazolam 1 mg/mL injectionAI (190 hospitals, 27,985–30,991 samples)
• NDC 64253-0900-91 — Calcium chloride injection 10%AI (358 hospitals, 29,765–30,989 samples)
• NDC 50383-0357-31 — Lactulose 10 g/15 mL oral solutionAI (35 hospitals, 30,089–30,989 samples)
• NDC 50383-0779-17 — Lactulose 10 g/15 mL oral solutionAI (69 hospitals, 30,089–30,989 samples)
• NDC 50383-0357-30 — Lactulose 10 g/15 mL oral solutionAI (49 hospitals, 30,089–30,989 samples)
• NDC 00527-1301-01 — primidone 50 mg tabletAI (371 hospitals, 30,496–30,982 samples)
• NDC 00121-0721-04 — Fluoxetine liquid for oral useAI (394 hospitals, 30,017–30,962 samples)
• NDC 60687-0333-01 — Lisinopril 20 mg tabletsAI (527 hospitals, 29,884–30,955 samples)
• NDC 47781-0428-11 — Fentanyl 72-hour skin patch, 100 mcg per hourAI (356 hospitals, 29,978–30,950 samples)
• NDC 00409-3977-01 — Bacteriostatic water for injectionAI (310 hospitals, 30,476–30,944 samples)
• NDC 00187-5100-01 — PIMECROLIMUS 1 % TOPICAL CREAMAI (188 hospitals, 29,971–30,943 samples)
• NDC 45802-0495-35 — DESOXIMETASONE 0.25 % TOPICAL CREAMAI (151 hospitals, 29,971–30,943 samples)
• NDC 00078-0501-61 — Rivastigmine 4.6 mg/24 hour skin patchAI (242 hospitals, 30,123–30,933 samples)
• NDC 00078-0503-61 — RIVASTIGMINE 13.3 MG/24 HOUR TRANSDERMAL PATCHAI (92 hospitals, 30,123–30,933 samples)
• NDC 00487-9801-01 — Ipratropium bromide 0.02% inhalation solutionAI (862 hospitals, 29,886–30,930 samples)
• NDC 67457-0999-02 — Sodium nitroprusside injection solutionAI (100 hospitals, 29,969–30,923 samples)
• NDC 59762-0131-04 — Silver sulfadiazine 1% creamAI (155 hospitals, 29,933–30,914 samples)
• NDC 51672-1302-00 — Terconazole 0.8% vaginal cream, 20 gram tubeAI (315 hospitals, 29,968–30,913 samples)